Research ArticleCardiovascular Physiology

Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury

See allHide authors and affiliations

Science Signaling  29 Oct 2013:
Vol. 6, Issue 299, pp. ra95
DOI: 10.1126/scisignal.2004225

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

NO More Heart Damage

Damage caused by the lack of oxygen and nutrients that occurs during myocardial ischemia can result in heart failure. A therapeutic strategy that helps to limit the effects of heart failure is to increase signaling through G protein–coupled receptors (GPCRs) by inhibiting GRK2 (GPCR kinase 2), a kinase that desensitizes GPCRs. Another therapeutic strategy provides S-nitrosothiols, such as nitric oxide, which can be added to proteins in a posttranslational modification called S-nitrosylation. Huang et al. found that the ability of S-nitrosothiols to enhance cardiomyocyte survival after ischemic injury required the S-nitrosylation of GRK2, a modification that inhibits this kinase. Mice bearing a form of GRK2 that could not be S-nitrosylated were more susceptible to cardiac damage after ischemia. These results suggest that therapeutic strategies that promote the S-nitrosylation of GRK2 could be used to treat heart failure after myocardial ischemia.